ReviewFrontiers in medicine2025
Artificial intelligence in advanced endoscopic imaging: transforming optical diagnosis in gastroenterology.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Global trends and hotspots in robot-assisted gastrointestinal endoscopy: a bibliometric and visualization analysis.Journal of robotic surgery · 2026Review
- The Role of Computational Models in the Detection of Colorectal Carcinoma and Precancerous Lesions.International journal of molecular sciences · 2026Review
- Artificial Intelligence for the Detection of Small Bowel Lesions and Neoplasia: A Scoping Review.Cureus · 2026Review
- Artificial intelligence in gastric cancer research: a bibliometric and visualized analysis from 1993 to 2026.Frontiers in oncology · 2026Review
- Mamba-based state-space modeling with window attention for explainable multi-class gastrointestinal disease diagnosis in endoscopic images.Frontiers in artificial intelligence · 2026Article
- Comparative analysis of endoscopic and histopathological findings in patients with chronic gastritis.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The term Artificial intelligence (AI) is revolutionizing gastrointestinal (GI) endoscopy by enhancing advanced imaging techniques such as Narrow Band Imaging (NBI), Linked Color Imaging (LCI), iSCAN, and Confocal Laser Endomicroscopy (CLE). AI-driven deep learning algorithms, particularly convolutional neural networks (CNNs) and transformer-based models, have demonstrated high accuracy in the real-time detection, classification, and risk stratification of premalignant and malignant lesions, thereby reducing unnecessary biopsies and improving diagnostic efficiency. In the upper GI tract, AI has shown superior performance in detecting dysplasia in Barrett's esophagus, distinguishing early gastric cancer from benign alterations, and predicting submucosal invasion depth. This capability enhances decision-making regarding endoscopic resection, such as endoscopic submucosal dissection (ESD). In the lower GI tract, AI is increasingly applied for real-time identification of adenomas, serrated lesions, and neoplastic changes in ulcerative colitis. Studies have confirmed that AI-assisted colonoscopy significantly increases adenoma detection rates, thereby reducing the incidence of interval colorectal cancer. Furthermore, AI-powered advanced endoscopy allows for a more objective assessment of mucosal and histological healing in IBD, helping predict outcomes and advancing precision medicine in its management. This narrative review comprehensively analyzes AI's role in advanced endoscopic imaging, highlighting its impact on optical diagnosis in both upper and lower GI pathologies. It explores the integration of multimodal AI approaches, which combine imaging data with clinical and molecular biomarkers, to enhance diagnostic precision. Additionally, it discusses current challenges, including the need for multicenter validation, standardization of AI algorithms, and ethical considerations for clinical implementation. Future perspectives emphasize the necessity for high-quality prospective studies to validate AI's real-world applicability and long-term benefits in endoscopic practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.